Innovation Pharmaceuticals Inc (IPIX): B-Oral Mucositis P2 interim results next...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Re: noretreat post# 175916

Tuesday, 03/21/2017 8:13:48 AM

Tuesday, March 21, 2017 8:13:48 AM

B-Oral Mucositis P2 interim results next week could be a very good boost as well.

I hope we see them next week.

Keep Last Read

Replies (1) Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM

InvestorsHub NewsWire

FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM

Only $200 per official company press release!